For instance, mutations in DARS2 (Scheper et al., 2007) and EARS2 (Steenweg et al., 2012) are associated with leukoencephalopathy, not necessarily seen in the clinical presentations of patients with other ARS2 variants. This evidence concerns the gene DARS2 and Leukoencephalopathy.